Search for: "Anda Pharmaceuticals, Inc"
Results 421 - 440
of 607
Sorted by Relevance
|
Sort by Date
15 Jul 2009, 5:15 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: European Commission Competition DG releases final report on pharmaceutical sector (IPKat) (PatLit) (BLOG@IP::JUR) (IAM) (Managing Intellectual Property) (Intellectual Property Watch) (The SPC Blog) (IAM) US: Follow-on biologics proposals considered by US Senate HELP Committee; Committee passes amendment for 12-year biologics exclusivity period… [read post]
7 Apr 2016, 6:25 am
Concordia Pharmaceuticals, Inc. v. [read post]
20 Jan 2011, 1:03 pm
Patent No. 7,101,574 ("the ‘574 patent") covering ANTARA (fenofibrate) Capsules, which is approved under NDA No. 21-695, and granted a Motion to Dismiss filed by defendants Ethypharm S.A., Lupin Limited, and Lupin Pharmaceuticals, Inc. [read post]
6 Oct 2010, 11:43 pm
Sepracor Inc., concerning Dey’s ANDAs for generic versions of Sepracor’s XOPENEX (levalbuterol HCl) – the U.S. [read post]
7 May 2012, 5:00 am
Mylan Pharmaceuticals, Inc., ___ F. [read post]
28 Mar 2011, 2:42 pm
Karst – Late last week, Par Pharmaceutical, Inc. [read post]
15 Apr 2010, 11:19 am
See Andrx Pharms., Inc. v. [read post]
13 Jan 2009, 8:41 am
Caraco Pharmaceutical: Whether DJ jurisdiction can exist after the patentee has granted an ANDA applicant a covenant not to sue. [read post]
9 Apr 2019, 8:03 pm
Teva Pharmaceuticals USA, Inc., 395 F.3d 1364 (Fed. [read post]
30 Jul 2013, 2:01 pm
Lexis 1688, at *36) to Merrell Dow Pharmaceuticals, Inc. v. [read post]
25 Mar 2011, 8:29 pm
" Duramed Pharmaceuticals v. [read post]
15 Aug 2012, 11:02 am
District Court for the District of Columbia by Watson Laboratories, Inc. [read post]
28 Oct 2010, 10:14 am
On June 28th, 2010, Sandoz Inc. replied to the Company’s correspondence. [read post]
5 Apr 2012, 1:41 pm
Karst – It was yet another exciting day in the Hatch-Waxman world when news broke Wednesday morning that Teva Pharmaceuticals USA, Inc. [read post]
13 Aug 2015, 10:56 am
Biogen Idec, Inc. is a case involving a brand-name pharmaceutical product which held that design defect claims against drug manufacturers are preempted as a matter of law. [read post]
10 Jun 2010, 3:58 am
Par Pharmaceutical, Inc. [read post]
21 Dec 2010, 11:00 am
(“Sandoz”) requests from the Agency a written decision that Cobrek Pharmaceuticals, Inc. [read post]
18 Jul 2011, 5:16 pm
Circuit’s March 2, 2010 decision in Teva Pharmaceuticals USA, Inc. v. [read post]
24 Apr 2007, 4:18 pm
Bridgewood Servs., Inc., 290 F.3d 1364, 1373 (Fed. [read post]
17 Apr 2009, 12:00 am
Ltd. sues 11 generics companies over Levaquin patents (Law 360) Lexapro (Escitalopram) – Netherlands District court invalidates Lundbeck’s patent EP ‘066 (IPKat) Lexapro (Escitalopram) - Baldwin’s rules explained (The SPC Blog) Lexapro (Escitalopram) – federal district Judge agrees to determine whether Forest Laboratories destroyed key documents (Law 360) Pegasys (PEG interferon alfa 2a) – Roche wins post grant opposition against Wockhardt… [read post]
